Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on US Healthcare Journal.
Press releases published on March 31, 2025
Compass Therapeutics to Host Webcast Highlighting Top-Line Clinical Data from the Ongoing Randomized Phase 2/3 Study Evaluating Tovecimig in Patients with Biliary Tract Cancer
GlobeNewswire
·
March 31, 2025
Webcast scheduled for Tuesday, April 1, 2025 at 8:00 AM ET. BOSTON, March 31, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based …
Ardelyx to Share a Post-Hoc Analysis of the OPTIMIZE Study Supporting XPHOZAH® (tenapanor) at the National Kidney Foundation Spring Clinical Meetings
GlobeNewswire
·
March 31, 2025
WALTHAM, Mass., March 31, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today …
Ascendis Submits U.S. NDA for TransCon CNP (Navepegritide) for the Treatment of Children with Achondroplasia
GlobeNewswire
·
March 31, 2025
— Data demonstrated multiple clinical benefits beyond linear growth — NDA supported by data from three randomized, double-blind, placebo-controlled clinical trials in children with achondroplasia, with up to three years of open-label extension data — …
Celcuity Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
GlobeNewswire
·
March 31, 2025
The PIK3CA wild-type cohort of the VIKTORIA-1 Phase 3 trial is on track to report topline data in Q2 2025 VIKTORIA-2 Phase 3 remains on track to enroll its first patient in Q2 2025 Presented encouraging preliminary overall survival data from the Phase 1b …
Bionano Reports Fourth Quarter and Full-Year 2024 Results and Provides Revenue Outlook for 2025
GlobeNewswire
·
March 31, 2025
SAN DIEGO, March 31, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the fourth quarter and full year ended December 31, 2024 and revenue outlook for 2025. “2024 has been an important year for Bionano. …
Daré Bioscience Reports Full Year 2024 Financial Results and Provides Company Update
GlobeNewswire
·
March 31, 2025
Enables women to access a solution that they want and need Creates an opportunity to accelerate revenue generation from this proprietary formulation Daré expects to start recording revenue and cash flow in the 4th quarter of this year Conference call today …
Ascilion to present at the 8th International Conference on Microneedles in Brisbane
EIN Presswire
·
March 31, 2025
Ascilion's products for dermal interstitial fluid sampling will be the focus of six different presentations at the Microneedles 2025 Conference. STOCKHOLM, SWEDEN, March 31, 2025 /EINPresswire.com/ -- Ascilion AB ("Ascilion") the leader in dermal …
Positron Corporation Secures $8 Million in Capital to Accelerate Growth and Market Expansion
GlobeNewswire
·
March 31, 2025
Niagara Falls, NY, March 31, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (OTC: POSC) (the “Company”), a leading molecular imaging medical device company specializing in Positron Emission Tomography (PET) and PET-CT imaging systems and clinical support …
Cytokinetics to Participate in the 24th Annual Needham Virtual Healthcare Conference
GlobeNewswire
·
March 31, 2025
SOUTH SAN FRANCISCO, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that members of the Company’s management team are scheduled to participate in a fireside chat at the 24th Annual Needham Virtual …
Eagle Pharmaceuticals Announces $69 Million Agreement to Monetize BENDEKA® Royalties
GlobeNewswire
·
March 31, 2025
WOODCLIFF LAKE, N.J., March 31, 2025 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced that it has entered into a royalty purchase agreement with an entity that was provided capital by funds managed …
Dogwood Therapeutics Announces Fourth Quarter and Full Year 2024 Financial Results
GlobeNewswire
·
March 31, 2025
-Dogwood Therapeutics, Inc. commenced dosing of patients in the Halneuron® Chemotherapy Induced Neuropathic Pain (“CINP”) Phase 2b Trial - - Halneuron® CINP P2b study interim data readout is expected in Q4 2025 - - Conversion of existing $19.5M in debt to …
New Book 'Late To Your Own Funeral' Aims to Transform the Conversation around Death for Younger Generations
EIN Presswire
·
March 31, 2025
Guide Offers Readers Practical and Relevant Estate Planning Strategies ATLANTA, GA, UNITED STATES, March 31, 2025 /EINPresswire.com/ -- Rachel Donnelly, founder and CEO of AfterLight, has released "Late To Your Own Funeral," a comprehensive guide …
Theriva™ Biologics anuncia resultados positivos de la segunda reunión del Comité independiente para la monitorización de los datos de VIRAGE, el ensayo clínico de Fase 2b de VCN-01 de la empresa en combinación con quimioterapia para el adenocarcinoma p…
GlobeNewswire
·
March 31, 2025
ROCKVILLE, Maryland, March 31, 2025 (GLOBE NEWSWIRE) -- Theriva™ Biologics (NYSE American: TOVX), una empresa diversificada en fase clínica que desarrolla terapias diseñadas para tratar el cáncer y enfermedades relacionadas en áreas de gran necesidad …
CORRECTION - Vaso Corporation Announces Financial Results for Fourth Quarter and Full Year 2024
GlobeNewswire
·
March 31, 2025
PLAINVIEW, N.Y., March 31, 2025 (GLOBE NEWSWIRE) -- Please note that, in a release issued under the same headline earlier today by Vaso Corporation (OTCQX: VASO), some figures in the written description of the financial results for the three months and the …
PracticeLink Announces New “First Practice Fund” Scholarship to Support Physicians
GlobeNewswire
·
March 31, 2025
ST. LOUIS and HINTON, West Virginia, March 31, 2025 (GLOBE NEWSWIRE) -- PracticeLink, the nation’s most trusted physician recruitment resource and home of the most widely used online physician job board, announces its new “First Practice Fund” scholarship …
Global Cannabis Cosmetics Market: Key Trends, Market Share, Growth Drivers, and Forecast for 2025-2034
EIN Presswire
·
March 31, 2025
The Business Research Company's Cannabis Cosmetics Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, March 31, 2025 /EINPresswire.com/ -- The cannabis cosmetics market has witnessed …
In-Depth Analysis of the Cannabis Infused Products Market: Key Drivers, Trends, Opportunities, and Forecast 2025-2034
EIN Presswire
·
March 31, 2025
The Business Research Company's Cannabis-Infused Products Global Market Report 2025 – Market Size, Trends, And Global Forecast 2023-2032 LONDON, GREATER LONDON, UNITED KINGDOM, March 31, 2025 /EINPresswire.com/ -- The Global Forecast: What Does The …
Lipella Pharmaceuticals Co-Founder Michael Chancellor Featured on the Pharmaverse Podcast
GlobeNewswire
·
March 31, 2025
PITTSBURGH, March 31, 2025 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella,” “our,” “us,” or the “Company”), a clinical-stage biotechnology company addressing serious diseases with significant unmet needs, today announced that Co- …
Sierra Tucson Partners with Blue Cross® Blue Shield® of Arizona
GlobeNewswire
·
March 31, 2025
TUCSON, Ariz., March 31, 2025 (GLOBE NEWSWIRE) -- Sierra Tucson is pleased to announce that it has partnered with Blue Cross® Blue Shield® of Arizona, an Independent Licensee of the Blue Cross Blue Shield Association. Being in network with this highly …
CLJA Veterans: Is Uncle Sam’s Marker Still Good on PACT Act EO Claims
GlobeNewswire
·
March 31, 2025
MURPHYSBORO, Ill., March 31, 2025 (GLOBE NEWSWIRE) -- Last week Congressman Mike Bost chaired the House Committee on Veterans’ Affairs on hearings raised by the subcommittees on Technology Modernization, Disability Assistance, and Memorial Affairs, …